HSV-2 spreads through direct skin-to-skin contact during vaginal, anal, or oral sex with someone who carries the virus. The contact doesn’t have to involve visible sores. People with HSV-2 shed the virus from genital skin on roughly 10 to 20 percent of days, and the majority of that shedding happens without any symptoms at all.
How the Virus Passes Between Partners
HSV-2 requires direct contact with infected skin, mucous membranes, or genital fluids to transmit. The virus can enter the body through the thin, moist tissue lining the genitals, anus, or mouth, and it can also pass through small breaks in regular skin. You can contract it through contact with a herpes sore, genital fluids from an infected partner, or skin in the genital area of someone carrying the virus, even when no sore is present.
The per-act transmission risk is estimated at about 1.7 percent, based on modeling that found it takes a median of roughly 40 sexual acts before the virus passes to a new partner. That number can shift significantly depending on whether shedding is occurring, whether protection is used, and the direction of transmission.
Why It Spreads Without Symptoms
Asymptomatic shedding is the main reason HSV-2 transmits so effectively. Among people who know they have genital HSV-2 and experience outbreaks, the virus is detectable on about 20 percent of days. Among people with HSV-2 who have never noticed symptoms, shedding still happens on about 10 percent of days. In that asymptomatic group, 84 percent of shedding episodes are entirely subclinical, meaning the person has no visible sores, tingling, or any sign that the virus is active on the skin’s surface.
This is why many people contract HSV-2 from a partner who genuinely didn’t know they were infectious. The virus periodically reactivates and travels to the skin surface in quantities that can be enough to infect a new host, all without the carrier noticing anything.
Women Face Higher Risk
In nearly every large study, women acquire HSV-2 at higher rates than men. The biological explanation is straightforward: women have a wider surface area of mucosal tissue in the genital area, and that tissue is thinner and more susceptible to viral entry. Men typically acquire HSV-2 through genital skin that has an outer layer of tougher, non-mucosal cells the virus must breach.
Condom effectiveness reflects this asymmetry. Condoms reduce male-to-female transmission by an estimated 96 percent per act, largely because they cover the primary shedding site. For female-to-male transmission, condoms reduce risk by about 65 percent, a meaningful but smaller benefit because the virus can shed from areas a condom doesn’t cover.
Oral HSV-2 Is Uncommon
HSV-2 can technically establish itself in the oral area through oral-genital contact, but it does so far less readily than HSV-1. In studies of people carrying both HSV-1 and HSV-2 antibodies, oral HSV-2 shedding was detected on only about 0.06 percent of days, compared to 1 percent for oral HSV-1 and 7 percent for genital HSV-2. When oral HSV-2 shedding does occur, it tends to cluster around a new genital infection or during a genital recurrence. The practical takeaway: receiving oral sex from someone with genital HSV-2 carries some theoretical risk, but oral HSV-2 reactivates so infrequently that onward transmission from the mouth is rare.
Transmission During Pregnancy
A mother can pass HSV-2 to her baby during vaginal delivery, but the risk depends enormously on timing. A first-ever genital herpes infection acquired near the time of delivery carries a transmission risk of about 57 percent, because the mother’s immune system hasn’t yet produced antibodies that help protect the baby. For women with a known history of recurrent genital herpes, the risk drops to roughly 2 percent, since existing antibodies cross the placenta and offer the newborn partial protection. This is why providers typically recommend a cesarean delivery when active genital lesions are present at the time of labor.
Surfaces and Non-Sexual Contact
HSV-2 can survive on dry surfaces for anywhere from a few hours to several weeks under laboratory conditions, with longer survival at lower humidity. In real-world settings, though, the virus degrades quickly and requires direct mucosal or broken-skin contact to establish infection. Transmission from toilet seats, towels, or shared objects is theoretically possible but has not been documented as a meaningful route. Direct skin-to-skin or skin-to-mucosa contact during sexual activity remains the overwhelmingly dominant mode of spread.
Self-transfer is a small but real possibility. Touching an active sore and then touching your eyes or another mucous membrane can move the virus to a new body site, particularly during a first outbreak when antibody levels are still low.
How to Reduce Transmission Risk
Consistent condom use is the most accessible protective measure, cutting per-act risk substantially, especially for male-to-female transmission. Daily suppressive antiviral therapy further reduces the rate of transmission in couples where one partner has HSV-2 and the other does not. Combining condoms with daily antivirals provides the greatest risk reduction, though neither method eliminates risk entirely because shedding can occur from skin not covered by a condom.
Avoiding sexual contact during outbreaks is important, since shedding rates and viral quantities are highest when sores are present. But given how much transmission happens during symptom-free periods, relying only on outbreak avoidance leaves significant gaps.
Incubation and Detection
After exposure, symptoms typically appear within six to eight days, though the incubation period can range from one to 26 days. Many people never develop noticeable symptoms at all, which is part of why the virus circulates so widely. Blood tests that detect HSV-2 antibodies (IgG) generally become reliable about 12 weeks after exposure, meaning a test taken too soon after a potential exposure may come back falsely negative.